Armata Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Armata Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q2 2024.
  • Armata Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -399 %, a 279% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -399 -623 -279% Jun 30, 2024
Q1 2024 -629 -782 -511% Mar 31, 2024
Q4 2023 -14.8K -14.9K -14588% Dec 31, 2023
Q3 2023 541 +441 +442% Sep 30, 2023
Q2 2023 224 +128 +133% Jun 30, 2023
Q1 2023 153 +60.5 +65.2% Mar 31, 2023
Q4 2022 102 +11.2 +12.3% Dec 31, 2022
Q3 2022 99.9 +25.7 +34.7% Sep 30, 2022
Q2 2022 95.9 +20.3 +26.8% Jun 30, 2022
Q1 2022 92.7 +17.7 +23.6% Mar 31, 2022
Q4 2021 91.1 +23.4 +34.5% Dec 31, 2021
Q3 2021 74.2 +13.2 +21.7% Sep 30, 2021
Q2 2021 75.6 +20.9 +38.1% Jun 30, 2021
Q1 2021 75 +24.4 +48.3% Mar 31, 2021
Q4 2020 67.7 +1.98 +3.01% Dec 31, 2020
Q3 2020 60.9 -5.78 -8.66% Sep 30, 2020
Q2 2020 54.8 -9.23 -14.4% Jun 30, 2020
Q1 2020 50.6 -7.7 -13.2% Mar 31, 2020
Q4 2019 65.7 +25.7 +64.2% Dec 31, 2019
Q3 2019 66.7 +43.7 +190% Sep 30, 2019
Q2 2019 64 +40.9 +177% Jun 30, 2019
Q1 2019 58.3 +31.4 +117% Mar 31, 2019
Q4 2018 40 -0.16 -0.4% Dec 31, 2018
Q3 2018 23 -47.5 -67.4% Sep 30, 2018
Q2 2018 23.1 -42.5 -64.8% Jun 30, 2018
Q1 2018 26.9 -29.6 -52.4% Mar 31, 2018
Q4 2017 40.2 -10.9 -21.3% Dec 31, 2017
Q3 2017 70.5 +24.4 +53% Sep 30, 2017
Q2 2017 65.5 +18 +38% Jun 30, 2017
Q1 2017 56.5 -21.7 -27.7% Mar 31, 2017
Q4 2016 51.1 -139 -73.1% Dec 31, 2016
Q3 2016 46.1 -261 -85% Sep 30, 2016
Q2 2016 47.5 -557 -92.1% Jun 30, 2016
Q1 2016 78.2 +1.14K Mar 31, 2016
Q4 2015 190 +577 Dec 31, 2015
Q3 2015 307 +607 Sep 30, 2015
Q2 2015 605 Jun 30, 2015
Q1 2015 -1.06K Mar 31, 2015
Q4 2014 -387 Dec 31, 2014
Q3 2014 -300 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.